Nov 26, 2018 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News
Allergan seeks to expand foot Allergan seeks to expand footprint with retinal therapy print with retinal therapy New research CHICAGO — At the Ophthalmology Innovation Summit at AAO, Jag Dosanjh, senior vice president of eye care for Allergan, discusses two new...
Nov 18, 2018 | AMD Research, Information, Latest News
A New Hope for Age-Related Macular Degeneration For years, innovators and ocular researchers have attempted to solve the issue of blindness caused by macular degeneration. Until recently, the outcome of this research has seen little meaningful treatment. However, a...
Nov 8, 2018 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News
Implantable Ranibizumab Port for Wet AMD Lasts Up to 15 Months by: Cecilia Pessoa Gingerich New data from the LADDER study of an implantable delivery system for ranibizumab (Lucentis) show that some patients with neovascular, or wet, age-related macular degeneration...
Nov 8, 2018 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News
Compact Imaging, Novartis collaborate to develop home retinal monitoring system Compact Imaging has signed a collaboration agreement with Novartis Pharma to develop a home-based monitor to detect progression of age-related macular degeneration and diabetic...
Oct 29, 2018 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News
Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration by: Matt Fellows In the study, patients were given faricimab in one of two extended dosing regimens – 6mg every 12 or 16 weeks – compared to 0.5mg of ranibizumab...
Oct 26, 2018 | age-related macular degeneration (ARMD), AMD Research, Information, Latest News
Hallucinations associated with brain hyperactivity in people with macular degeneration University of Queesnland New research from the University of Queensland has shown for the first time that visual hallucinations in people with macular degeneration are associated...
Recent Comments